TrialEuropean heart journal2015

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.

Yasuhiko Sakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.